SK Bioscience and GC Green Cross, two major companies in domestic vaccine development, have entered the patch-type vaccine market. Known as the "pain-free injection," patch-type vaccines are ...
SK Group is making a bold $5.8 billion move to clean up its balance sheet and reorganize its energy empire. The South Korean conglomerate plans to raise 8 trillion won by year-end, primarily through a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback